1.ISOLATION AND PURIFICATION OF HUMAN FIBRONECTIN,PREPARATION OF ANTISERA AND ITS PRACTICAL USE
Fan LI ; Qiyin ZHANG ; Yiju CHEN ; Ziqin ZHAO ; Wenqing WU ; Yunju GU
Chinese Journal of Forensic Medicine 1988;0(04):-
The fibronectin was purified from human plasma by Gelatin-Sepharose 4B affinity chromatography. The rabbits were immunized with the fibronectin. the raw anti-fibronectin sera were absorbed bythe solid phase of the fibronectin free human serum. Then the specific anti-fibronectin sera were obtained. The fibronectins deposited on human bullet wounds, incised wounds as well as on blunt forceinJuries were demonst.ated by PAP immunohistochemical study using diluted anti-fibronectin serum.The results were quite sati factory.
2.Reduction and control of school bullying is urgently needed
Chinese Journal of Epidemiology 2017;38(3):277-279
School bullying and campus violence is a widespread social problem in the world.School bullying is characterized by its repeatability and suddenness,which could make the victims suffering from both psychological and health damage,and even affect their personality growth.Government should pay close attention to the reduction and control of school bullying and campus violence by establishing school bullying emergency response system and preparedness plan.The school and teacher's role and legal responsibility in the service and management in schools should be cleared and defined.It is necessary to help teachers conduct early detection and intervention for school bullying,conduct morality,mental health and legal educations in students to teach them to act according to the law and protect themselves according to the law and help them identify and avoid risks,encourage the establishment of rescue facility and web of anti-school bullying by non-government organizations,and set hotline for school bullying incident to reduce the incidence of school bullying.
3.Mutations analysis in a pedigree with maternally inherited sensorineural hearing loss.
Chunhong XU ; Haijun ZHANG ; Yiju ZHANG ; Suying ZHAO ; Xuexia GENG ; Yunfeng SHAN ; Xiangnian SHAN
Chinese Journal of Medical Genetics 2005;22(2):125-128
OBJECTIVETo analyze the mutations in a pedigree with maternally inherited sensorineural hearing loss, and to investigate whether 235delC heterozygote mutation in gap junction protein beta 2 (GJB2) gene modulates the severity of hearing loss associated with the A1555G mitochondrial mutation.
METHODSThe PCR products were digested with the Alw26 I restriction enzyme, followed by direct sequencing to detect the mitochondrial mutations in 72 members of a core pedigree of an extensive family with matrilineal nonsyndromic deafness; 235delC mutation of the GJB2 gene was screened in this family by using the Apa I restriction enzyme and direct sequencing.
RESULTSThe A1555G mutation of the mitochondrial DNA was present in all 27 members of maternal line, out of them, 21 members had phenotype of deafness (77.8%), with a high penetrance. Only three maternal line members of 72 members possessed 235delC heterozygote mutations, and the three had different phenotypes.
CONCLUSIONThe A1555G homozygous mutation of mitochondrial DNA is the susceptive etiological factor of nonsyndromic deafness in this family, but in the study of this pedigree, the 235delC heterozygous mutation in GJB2 gene may not aggravate the symptoms of hearing loss associated with the A1555G mitochondrial mutation.
Base Sequence ; Connexin 26 ; Connexins ; genetics ; DNA Mutational Analysis ; DNA, Mitochondrial ; chemistry ; genetics ; Female ; Hearing Loss, Sensorineural ; genetics ; Heterozygote ; Humans ; Male ; Mutation ; Pedigree ; Polymerase Chain Reaction
4.Analysis of curative effect of cisplatin combined with gemcitabine and cis-platin plus paclitaxel in the treatment of advanced non-small cell lung cancer
Yongtao WEN ; Zhaobang WANG ; Yiju ZHAO ; Qiuting LIANG ; Jie CAI
China Modern Doctor 2015;(3):74-76
Objective To investigate the curative effect of cisplatin combined with gemcitabine and cisplatin plus pacli-taxel in the treatment of advanced non-small cell lung cancer. Methods All 100 patients with non-small cell lung can-cer in our hospital from January 2012 to January 2014 in our hospital, randomly divided into observation group (gemc-itabine+cisplatin, GP group) and control group (paclitaxel+cisplatin, TP group), each group had 50 cases, two groups of patients every 21 days for a cycle, observed curative effect after 2 cycles, toxic and adverse reaction were compared between the two groups. Results The effective rate of the observation group after treatment was 42.0%(21/50),was higher than that of the control group 40% (20/50), but there was no significant difference (P>0.05). Conclusion Cura-tive effect of cisplatin combined with gemcitabine and cisplatin plus paclitaxel in the treatment of advanced non-small cell lung cancer is similar, the poisonous side effect is different and can be tolerated, for the treatment of advanced non-small cell lung cancer treatment plan better.